4 - Taysha Gene Therapies, Inc.

Form 4 - Statement of changes in beneficial ownership of securities: SEC Accession No. 0001665124-26-000011

Filing Date: 2026-04-13

Accepted: 2026-04-13 16:33:58

Documents: 1

Period of Report: 2026-04-10

Nagendran Sukumar ( Reporting ) CIK : 0001665124 (see all company filings) Type: 4 | Act: 34 | File No.: 001-39536 | Film No.: 26858171

1 | form4-04132026_080454.xml | 4 | 7967